Related Experiment Video
Updated: Aug 4, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia
1Department of Internal Medicine, Virginia Commonwealth University, USA.
Abstract:
Sterol 27-hydroxylase (CYP27A1) may defend cells against accumulation of excess cholesterol, making this enzyme a possible target in the management of hyperlipidemia. The study objective was to analyze cholesterol homeostatic responses to increases in CYP27A1 activity in HepG2 cells and primary human hepatocytes. Increasing CYP27A1 activity by increasing enzyme expression led to significant increases in bile acid synthesis with compensatory increases in HMG-CoA reductase (HMGR) activity/protein, LDL receptor (LDLR) mRNA, and LDLR-mediated cholesterol uptake. Under these conditions, only a small increase in cellular 27-hydroxycholesterol (27OH-Chol) concentration was observed. No changes were detected in mature sterol regulatory element-binding proteins (SREBP) 1 or 2. Increasing CYP27A1 activity by increasing mitochondrial cholesterol transport (i.e., substrate availability) led to greater increases in bile acid synthesis with significant increases in cellular 27OH-Chol concentration. Mature SREBP 2 protein decreased significantly with compensatory decreases in HMGR protein. No change was detected in mature SREBP 1 protein. Despite increasing 27OH-Chol and lowering SREBP 2 protein concentrations, LDLR mRNA increased significantly, suggesting alternative mechanisms of LDLR transcriptional regulation. These findings suggest that regulation of liver mitochondrial cholesterol transport represents a potential therapeutic strategy in the treatment of hyperlipidemia and atherosclerosis.
Insights
Sterol 27-hydroxylase (CYP27A1) activity influences cholesterol balance. Regulating mitochondrial cholesterol transport, not just enzyme expression, offers a potential therapeutic strategy for hyperlipidemia and atherosclerosis.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Sterol 27-hydroxylase (CYP27A1) plays a role in cholesterol metabolism.
- CYP27A1 is a potential therapeutic target for hyperlipidemia.
Purpose of the Study:
- To investigate cholesterol homeostasis in response to altered CYP27A1 activity.
- To compare the effects of increasing CYP27A1 expression versus substrate availability.
Main Methods:
- Utilized HepG2 cells and primary human hepatocytes.
- Manipulated CYP27A1 activity through enzyme expression and mitochondrial cholesterol transport.
- Assessed bile acid synthesis, cholesterol levels, and regulatory protein/mRNA expression (HMGR, LDLR, SREBP).
Main Results:
- Increased CYP27A1 expression led to increased bile acid synthesis, HMGR, and LDLR uptake, with minimal 27-hydroxycholesterol (27OH-Chol) increase.
- Increased mitochondrial cholesterol transport resulted in higher bile acid and 27OH-Chol levels, decreased SREBP 2 and HMGR, but increased LDLR mRNA.
- LDLR mRNA increased despite lower SREBP 2, suggesting alternative regulatory pathways.
Conclusions:
- Regulation of liver mitochondrial cholesterol transport is a potential therapeutic strategy for hyperlipidemia.
- CYP27A1 activity impacts cholesterol homeostasis through multiple pathways.
- Alternative mechanisms may regulate LDLR transcription independently of SREBP 2.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Angina IV: Management
Atherosclerosis III: Management

